Document Actions
Pharmaceuticals Policy in the EU
Latest news on the pharmaceutical policies of the European Union.
- Pharma reform to tackle medicines shortages in EU — 20 March 2024, 23:10 CET
-
An EU Parliament committee adopted proposals Wednesday to revamp EU pharmaceutical legislation to foster innovation and enhance the security of supply, accessibility and affordability of medicines.
- Brussels opens participation to Critical Medicines Alliance — 16 January 2024, 18:55 CET
-
The European Commission's Health Emergency Preparedness and Response Authority (HERA) launched Tuesday an open call for expression of interest to join the Critical Medicines Alliance.
- EU acts to address shortage of critical medicines — 24 October 2023, 23:43 CET
-
The European Commission adopted Tuesday a set of actions to better prevent and mitigate critical medicine shortages in the EU, this winter, next winter and beyond.
- Medicine Shortages in the EU - guide — 24 October 2023, 21:27 CET
-
The European Commission adopted on 24 October a set of actions to better prevent and mitigate critical medicine shortages in the EU, this winter, next winter and beyond.
- Brussels fines pharma companies EUR 13.4m in antitrust cartel settlement — 19 October 2023, 22:21 CET
-
The EU fined Alkaloids of Australia, Alkaloids Corporation, Boehringer, Linnea and Transo-Pharm a total of EUR13.4 million Thursday for taking part in a cartel concerning a key pharmaceutical ingredient.
- EU institutions strike deal on sustainable and flexible fee system — 26 September 2023, 12:23 CET
-
EU Council and European Parliament negotiators reached a provisional deal Monday on a regulation to modernise and simplify the structure of fees payable to the European Medicines Agency.
- EU acts to prevent winter shortages of antibiotics — 17 July 2023, 21:51 CET
-
The Commission and the European Medicines Agency issued recommendations Monday for avoiding shortages of key antibiotics used to treat respiratory infections in the next winter season.
- EU steps up fight against antimicrobial resistance — 13 June 2023, 23:33 CET
-
The EU Council adopted Tuesday a recommendation aimed at stepping up EU action to combat antimicrobial resistance (AMR) in the fields of human health, animal health and the environment.
- EU Commission agreement with BioNTech-Pfizer on the delivery of vaccines - guide — 26 May 2023, 23:27 CET
-
The EU Commission, acting with EU states and vaccine developers BioNTech-Pfizer, reached an agreement on 26 May to better address Member States' assessment of evolving needs for COVID-19 vaccines.
- Supplementary Protection Certificates - guide — 27 April 2023, 18:55 CET
-
The European Commission on 27 April proposed new rules to help companies, especially small and medium-sized companies (SMEs), make the most of their inventions, leverage new technologies and contribute to the EU's competitiveness and technological sovereignty.
- EU pharma legislation set for major reform — 27 April 2023, 21:42 CET
-
The Commission proposed Wednesday the largest reform of EU pharmaceutical legislation in over 20 years - with the aims of promoting innovation and ensuring patient access to affordable medicines.
- Revision of EU pharmaceutical legislation - guide — 26 April 2023, 18:25 CET
-
The European Commission proposed on 26 April to revise the EU's pharmaceutical legislation - the largest reform in over 20 years - to make it more agile, flexible, and adapted to the needs of citizens and businesses across the EU. The revision will make medicines more available, accessible and affordable.
- Council Recommendation on stepping up EU actions to combat AMR in a One Health approach - guide — 26 April 2023, 18:28 CET
-
The European Commission proposed on 26 April 2023 a major revision of the EU's pharmaceutical legislation. The package also includes a proposal for a Council Recommendation containing complementary measures to combat AMR in the fields of human health, animal health and the environment, through the so-called One Health approach.
- EU must learn lessons from COVID-19 vaccine procurement: auditors — 13 September 2022, 18:21 CET
-
The EU needs to learn lessons as to whether the Commission and Member States procured COVID-19 vaccines effectively, the EU's auditors said in a special report published Tuesday.
- Proposal to ensure continued supply of medicines to Northern Ireland, as well as Cyprus, Ireland and Malta — 12 April 2022, 23:35 CET
-
The EU Council adopted on 12 April proposals to ensure the continued long-term supply of medicines from Great Britain to Northern Ireland and to address outstanding supply concerns in Cyprus, Ireland and Malta.
- Europe builds preparedness against potential health threats — 08 April 2022, 17:39 CET
-
The EU moved Wednesday to bolster its capacity to respond to public health risks with a decontamination reserve and a new stockpile of equipment tailored to chemical, biological or nuclear emergencies.
- EU looks to tighten vaccine export controls — 25 March 2021, 20:52 CET
-
The European Commission introduced new, tougher criteria of 'reciprocity and proportionality' Wednesday under its transparency and authorisation mechanism for COVID-19 vaccine exports.
- Brussels extends export controls for COVID-19 vaccines — 11 March 2021, 23:09 CET
-
As Europe continues to suffer delays in some deliveries of vaccines, the EU Commission extended Thursday its 'transparency and authorisation' mechanism for COVID-19 vaccine exports to end June.
- 4m doses of BioNTech-Pfizer vaccine for EU's coronavirus hotspots — 10 March 2021, 22:15 CET
-
The EU Commission reached an agreement with BioNTech-Pfizer Wednesday for the supply of four million more doses of COVID-19 vaccines for Member States in order to tackle coronavirus hotspots.
- EU agency needs to be more open in pandemic response: Ombudsman — 10 February 2021, 21:05 CET
-
The EU Ombudsman called Tuesday for greater transparency and public scrutiny at Europe's disease prevention agency, as part of a wide-ranging enquiry into how EU institutions responded to the pandemic.
- New EU pharma strategy to make medicines affordable — 26 November 2020, 17:21 CET
-
A new pharmaceutical strategy, adopted Wednesday by the EU Commission, offers patients access to affordable medicines and supports competitiveness and innovation in Europe's pharma industry.
- A Pharmaceutical Strategy for Europe - guide — 25 November 2020, 16:49 CET
-
The European Commission adopted on 25 November a Pharmaceutical Strategy for Europe to ensure patients have access to innovative and affordable medicines and to support the competitiveness, innovative capacity and sustainability of the EU's pharmaceutical industry.
- EU approves BioNTech -Pfizer contract for access to vaccine — 12 November 2020, 17:01 CET
-
The Commission approved a fourth contract with pharmaceutical companies BioNTech and Pfizer Wednesday, providing for an initial purchase of 200 million doses on behalf of all EU Member States.
- Brussels signs first contract with AstraZeneca — 31 August 2020, 23:58 CET
-
The first pharmaceutical contract negotiated by the EU Commission on behalf of EU Member States entered into force Thursday following the formal signature between AstraZeneca and the Commission.
- Brussels concludes talks with fifth vaccine manufacturer — 25 August 2020, 00:25 CET
-
The EU concluded exploratory talks with U.S. based company Moderna Monday to purchase a potential vaccine against COVID-19 - the fifth company with which the Commission has concluded talks.